Nav1.7 sodium ion channel (Purdue/AnaBios)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameNav1.7 sodium ion channel (Purdue/AnaBios)
Drug Alias Namesodium channel blockers (Purdue)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type IX alpha subunit modulators
TargetsSodium channel protein type IX alpha subunit
Therapy Area/IndicationsPainNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPurdue Pharma Lp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAnabios CorpPurdue Pharma Lp
Active IndicationsN/A
Inactive IndicationsPainNeuralgia

Other Information

ATC CodeN/A
Related LinksN/A